Progression of peripheral joint disease in psoriatic arthritis: A 5-yr prospective study

Rheumatology

Volumn 42, Issue 6, 2003, Pages 778-783

  McHugh, N J ^a   Balachrishnan, C ^a   Jones, S M ^a  

^a ROYAL NATIONAL HOSPITAL FOR RHEUMATIC DISEASES   (United Kingdom)

Author keywords

Mortality; Outcome; Psoriasis; Psoriatic arthritis; Spondylarthropathy

Indexed keywords

AURANOFIN; AUROTHIOMALATE; AZATHIOPRINE; HYDROXYCHLOROQUINE; HYDROXYUREA; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; SALAZOSULFAPYRIDINE; ANTIRHEUMATIC AGENT; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NAIL DISEASE; PATIENT MONITORING; PLASMA VISCOSITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSORIATIC ARTHRITIS; QUESTIONNAIRE; RETROSPECTIVE STUDY; SCORING SYSTEM; SKIN DISEASE; SPONDYLITIS; TREATMENT PLANNING; WILCOXON SIGNED RANKS TEST; ADOLESCENT; BLOOD; CHILD; HOSPITALIZATION; MIDDLE AGED; ONSET AGE; PATHOLOGY; PATHOPHYSIOLOGY; PRESCHOOL CHILD; SURVIVAL RATE;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NAIL DISEASES; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE;

EID: 0038603010     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keg217     Document Type: Article

References (28)

1. McGonagle D, Conaghan PG, Emery P. Psoriatic arthritis: a unified concept twenty years on [published erratum appears in Arthritis Rheum 1999;42:1997]. Arthritis Rheum 1999;42:1080-6.
2. Kaipiamen-Seppanen O. Incidence of psoriatic arthritis in Finland. Br J Rheumatol 1996;35:1289-91.
3. Shbeeb M, Uramoto KM, Gibson LE, O'Fallon WM, Gabriel SE. The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982-1991. J Rheumatol 2000;27:1247-50.
4. Harrison BJ, Silman AJ, Barrett EM, Scott DG, Symmons DP. Presence of psoriasis does not influence the presentation or short-term outcome of patients with early inflammatory polyarthritis. J Rheumatol 1997;24:1744-9.
5. Stafford L, Kane D, Murphy E et al. Psoriasis predicts a poor short-term outcome in patients with spondylarthropathy. Arthritis Rheum 2001;45:485-93.
6. Gladman DD, Stafford-Brady F, Chang CH, Lewandowski K, Russell ML. Longitudinal study of clinical and radiological progression in psoriatic arthritis. J Rheumatol 1990; 17:809-12.
7. Jones SM, Armas JB, Cohen MG, Lovell CR, McHugh NJ. Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease. Br J Rheumatol 1994;33:834-9.
8. Hanly JG, Russell ML, Gladman DD. Psoriatic spondyloarthropathy: a long term prospective study. Ann Rheum Dis 1988;47:386-93.
9. Torre AJ, Rodriguez PA, Arribas CJ, Ballina GJ, Riestra NJ, Lopez LC. Psoriatic arthritis (PA): a clinical, immunological and radiological study of 180 patients. Br J Rheumatol 1991;30:245-50.
10. Mease PJ, Goffe BS, Metz J, VanderStoep A, Finck B, Burge DJ. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial. Lancet 2000;356:385-90.
11. Moll JM, Wright V. Psoriatic arthritis. Semin Arthritis Rheum 1973;3:55-78.
12. Marsal S, Armadans-Gil L, Martinez M, Gallardo D, Ribera A, Lience E. Clinical, radiographic and HLA associations as markers for different patterns of psoriatic arthritis. Rheumatology 1999;38:332-7.
13. Helliwell PS, Hetthen J, Sokoll K et al. Joint symmetry in early and late rheumatoid and psoriatic arthritis: comparison with a mathematical model. Arthritis Rheum 2000; 43:865-71.
14. Fredriksson T, Pettersson U. Severe psoriasis - oral therapy with a new retinoid. Dermatologica 1978;157:238-44.
15. Fries JF, Spitz PW, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137-45.
16. Helliwell P, Marchesoni A, Peters M, Barker M, Wright V. A re-evaluation of the osteoarticular manifestations of psoriasis. Br J Rheumatol 1991;30:339-45.
17. Punzi L, Pianon M, Rossini P, Schiavon F, Gambari PF. Clinical and laboratory manifestations of elderly onset psoriatic arthritis: a comparison with younger onset disease. Ann Rheum Dis 1999;58:226-9.
18. Gladman DD, Farewell VT, Nadeau C. Clinical indicators of progression in psoriatic arthritis: Multivariate relative risk model. J Rheumatol 1995;22:675-9.
19. Gladman DD, Farewell VT. The role of HLA antigens as indicators of disease progression in psoriatic arthritis: Multivariate relative risk model. Arthritis Rheum 1995;38:845-50.
20. Gladman DD, Farewell VT. Progression in psoriatic arthritis: role of time varying clinical indicators. J Rheumatol 1999;26:2409-13.
21. Gladman DD, Hing EN, Schentag CT, Cook RJ. Remission in psoriatic arthritis. J Rheumatol 2001; 28:1045-8.
22. Blackmore MG, Gladman DD, Husted J, Long JA, Farewell VT. Measuring health status in psoriatic arthritis: The Health Assessment Questionnaire and its modification. J Rheumatol 1995;22:886-93.
23. Husted JA, Gladman DD, Long JA, Farewell VT. A modified version of the Health Assessment Questionnaire (HAQ) for psoriatic arthritis. Clin Exp Rheumatol 1995; 13:439-43.
24. Husted JA, Gladman DD, Farewell VT, Cook RJ. Health-related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritis. Arthritis Rheum 2001;45:151-8.
25. Sokoll KB, Helliwell PS. Comparison of disability and quality of life in rheumatoid and psoriatic arthritis. J Rheumatol 2001;28:1842-6.
26. Roberts MET, Wright V, Hill AGS, Mehra AC. Psoriatic arthritis: follow-up study. Ann Rheum Dis 1976; 35:206-12.
27. Jones SM, Harris CP, Lloyd J, Stirling CA, Reckless JP, McHugh NJ. Lipoproteins and their subfractions in psoriatic arthritis: identification of an atherogenic profile with active joint disease. Ann Rheum Dis 2000;59:904-9.
28. Wong K, Gladman DD, Husted J, Long J, Farewell VT. Mortality studies in psoriatic arthritis. Results from a single clinic. I. Causes and risk of death. Arthritis Rheum 1997;40:1868-72.